Norcapto (Nortriptyline)

Nortriptyline acts within the central nervous system to alleviate depressive conditions.

• Major depressive disorder: reduces depressive symptoms and improves functional capacity in adults.
• Depressive symptoms associated with chronic illness: helps manage co‑morbid depression in patients with long‑term health conditions.
• Treatment‑resistant depression: may be considered when first‑line antidepressants have been ineffective.

• Nortriptyline inhibits the reuptake of norepinephrine and serotonin at neuronal synapses, increasing their extracellular concentrations. This enhances neurotransmission in pathways that regulate mood, thereby exerting antidepressant effects. The drug also exhibits antagonistic activity at histamine H1, muscarinic acetylcholine, and alpha‑adrenergic receptors, contributing to its side‑effect profile.

Nortriptyline may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Dry mouth: reduced salivation leading to discomfort.
• Constipation: slowed gastrointestinal motility.
• Drowsiness or sedation: increased sleepiness, especially after initiation.
• Weight gain: gradual increase in body weight.
• Blurred vision: temporary visual disturbances.
• Urinary retention: difficulty emptying the bladder.

Serious or Rare Side Effects

• Cardiac arrhythmia: irregular heart rhythm, potentially life‑threatening.
• Seizures: heightened risk in predisposed individuals.
• Severe hypotension: sudden drop in blood pressure causing dizziness.
• Serotonin syndrome: potentially fatal condition when combined with other serotonergic agents.
• Agranulocytosis: marked reduction in white blood cells, increasing infection risk.

Before initiating therapy, clinicians should evaluate specific safety considerations.

• Monitor cardiac function: obtain baseline ECG in patients with cardiac history.
• Assess suicidal ideation: closely observe patients during early treatment phases.
• Avoid abrupt discontinuation: taper dose under medical supervision to prevent withdrawal.
• Use cautiously in elderly: increased sensitivity to anticholinergic and sedative effects.
• Contraindicated in recent myocardial infarction: risk of arrhythmias.
• Store at ambient temperature: keep in the original container, protect from moisture and light.

Nortriptyline can interact with several medication classes, requiring careful management.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): risk of severe serotonin syndrome.
• Selective serotonin reuptake inhibitors (SSRIs) and other serotonergic agents: heightened serotonin toxicity.
• Other tricyclic antidepressants: additive cardiotoxic effects.
• Linezolid or meperidine: increased potential for serotonin syndrome.

Moderate Interactions (Monitor Closely)

• CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may raise nortriptyline plasma levels.
• Antihistamines and anticholinergics: amplify anticholinergic side effects.
• CNS depressants (e.g., alcohol, benzodiazepines): enhance sedation and respiratory depression.